BHVN
BHVN
NYSE · Biotechnology

Biohaven Ltd

$8.39
-0.35 (-4.00%)
As of Mar 24, 10:02 PM ET ·
Day Range $8.28 — $8.70
52W Range $7.48 — $40.82
Open$8.56
Previous Close$8.74
Day High$8.70
Day Low$8.28
52W High$40.82
52W Low$7.48
Volume
Avg Volume2.37M
Market Cap1.65B
P/E Ratio
EPS$-7.60
SectorBiotechnology

Analyst Ratings

Strong Buy
24 analysts
18 Buy 6 Hold 0 Sell
Price Target +258.3% upside
Current
$8.39
Target
$30.06
$17.22 $30.06 avg $35.82

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 166.56M 159.79M 165.80M
Net Income 26.40M 27.52M 28.79M
Profit Margin 15.9% 17.2% 17.4%
EBITDA 53.49M 47.96M 56.14M
Free Cash Flow 17.32M 22.87M 17.57M
Rev Growth +0.5% -2.4% +23.6%
Debt/Equity 0.62 0.47 0.55

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $207.18 +0.96% 166.6 397.77B
AMGN Amgen Inc $353.93 +1.58% 24.4 188.06B
GILD Gilead Sciences Inc $138.26 +0.11% 20.0 170.34B
VRTX Vertex Pharmaceuticals Inc $454.97 +1.42% 29.2 115.53B
REGN Regeneron Pharmaceuticals $749.47 +1.05% 17.9 80.50B
ALNY Alnylam Pharmaceuticals Inc $328.70 +6.70% 139.7 43.84B

BHVN News

No news for BHVN yet

Quick Stats

Market Cap1.65B
P/E Ratio
EPS$-7.60
Volume
SectorBiotechnology